Is VREX worth buying
Is it worth buying
Data confidence: high (3/3)
37×0.4 + 70×0.35 + 65×0.25 → 55
VREX's strength is in the technical picture: of 13 technical measures checked, 10 point up and 1 point down, and also in delivery against expectations: in the last four reports the company beat the earnings estimate 4 times and the revenue estimate 2 times.
The weakness is in how the market reacts to reports: the stock fell after most of those reports despite the beats — an average of 3.6% on the following session, and also in the company's own numbers: the company is still lossmaking — net margin is -10%.
In the background, last quarter 5 of the large holders added and 2 trimmed, and 2 opened a new position, and over the past three months the stock beat the index by 20.0 percentage points.
So what is identified here is a chart move only: the company's numbers do not hold it up, and anything built on it rests on timing, not on the business.
This read changed today.
Computed analysis from public data — not investment advice or a recommendation.
Risk flags
These are the things that can break the picture above. Each one is checked against a dated official source.
Stretched above the mean
Price is stretched over 8.0× ATR above its 20-day mean.
A stretched move usually snaps back hard — a late entry eats the whole drop.
— Not enough short data for a reliable gauge.
Based on short density and cover pace — a load gauge, not a price forecast.
The levels in the plan below are set to limit damage, not to maximise gain — in this state they shift within hours. Check live before acting.
The chart is in a supportive trend — timing is positive.
Fundamental quality or the price works against the stock.
Market backdrop: Positive market (Risk-On).
Financial health
Leaning negative
37/1002 of 8 checks are positive, 4 negative.
Revenue grew 2% versus the same quarter a year ago. The growth rate is slowing. The company is still lossmaking — net margin is -10%. Earnings per share cannot be compared off a negative base. Free cash flow of -$31M over the past year — -4% of revenue. The company spends more cash than it takes in.
All the numbers in ProTechnical analysis
Leaning positive
70/1004 of 7 checks are positive, 1 negative.
Of 13 technical measures checked, 10 point up and 1 point down. Price is 57.7% above the 200-day average. Above the long average is an uptrend. The relative strength index reads 92. Above 70 is considered overbought.
All the numbers in ProMarket psychology
Leaning positive
65/1005 of 9 checks are positive, 2 negative. (1 checks have no data.)
Last quarter 5 of the large holders added and 2 trimmed, and 2 opened a new position. Over the past three months the stock beat the index by 20.0 percentage points. Neuberger Berman Group, LLC increased its position by 30%.
All the numbers in ProThe company's future
Mixed
49/1001 of 5 checks are positive, 1 negative.
the stock fell after most of those reports despite the beats — an average of 3.6% on the following session. The market already prices the beats in; a good report alone no longer moves the stock. In the last four reports the company beat the earnings estimate 4 times and the revenue estimate 2 times. The money the company spends is going into research and development.
All the numbers in ProThese are market expectations about the future — not facts or a promise, and they change often.
Next-year earnings estimates moved +1% over the last 3 months.
The market is getting more optimistic.
~20% growth expected next year · מכפיל רווח עתידי 17.
Most of the future is priced — less room for error.
The price is 3% above the average analyst target.
The price has already passed what its analysts expect.
Entry strategy · VREX
PRO$20/month after the trial · cancel anytime
Bottom line: the company's numbers — leaning negative; the technical picture — leaning positive; and how the market behaves around it — leaning positive. The single largest risk here is that the stock fell after most of those reports despite the beats — an average of 3.6% on the following session. The market already prices the beats in; a good report alone no longer moves the stock. What would change the read: A quarter in which free cash flow turns positive again.
All data, scores and signals on this page are produced by an automated system and based on technical and quantitative data only. They are not investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional. Trading securities involves substantial risk, up to the full loss of your investment; every decision is your sole responsibility.